LIVE: Covaxin Phase 3 Trials Efficacy At 81 Per Cent, Says Bharat Biotech

Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial...

from NDTV News - Special https://ift.tt/30ecnxO
via